SCHEMBL5356447

SCHEMBL5356447

COc1ccc(C(=O)c2cn(C(C)C)c3ncnc(N)c23)cc1N(C(N)=O)c1ccccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.51
NTRK1 P04629 4/20 0.44
NTRK2 Q16620 3/20 0.44
KCNH2 Q12809 3/20 0.44
NTRK3 Q16288 2/20 0.44
PDPK1 O15530 3/20 0.42
RET P07949 6/20 0.41
KDR P35968 5/20 0.40
LCK P06239 4/20 0.40
TEK Q02763 3/20 0.40
EIF2AK3 Q9NZJ5 1/20 0.40
SRC P12931 3/20 0.39
EGFR P00533 2/20 0.38
PIK3CD O00329 2/20 0.38
PIK3CA P42336 2/20 0.38
PIK3CB P42338 2/20 0.38
PIK3CG P48736 2/20 0.38
PRKDC P78527 2/20 0.38
ABL1 P00519 1/20 0.38
HCK P08631 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5350777 0.94 PDGFRB (0.49) PDGFRBNTRK1NTRK2KCNH2NTRK3
SCHEMBL5364437 0.91 NTRK1 (0.48) PDGFRBNTRK1NTRK2KCNH2NTRK3
SCHEMBL6220214 0.91 PDGFRB (0.47) PDGFRBNTRK1NTRK2KCNH2NTRK3
SCHEMBL6223880 0.90 PDGFRB (0.49) PDGFRBNTRK1NTRK2KCNH2NTRK3
SCHEMBL6220539 0.88 PDGFRB (0.55) PDGFRBNTRK1NTRK2KCNH2NTRK3
SCHEMBL6220911 0.88 PDGFRB (0.53) PDGFRBNTRK1NTRK2KCNH2NTRK3
SCHEMBL6223276 0.85 PDGFRB (0.46) PDGFRBNTRK1NTRK2KCNH2NTRK3
SCHEMBL6220940 0.85 PDGFRB (0.48) PDGFRBNTRK1NTRK2KCNH2NTRK3
SCHEMBL6224467 0.85 NTRK1 (0.50) PDGFRBNTRK1NTRK2KCNH2NTRK3
SCHEMBL6222997 0.84 NTRK1 (0.48) PDGFRBNTRK1NTRK2KCNH2NTRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271262-B2 Pyrrolopyrimidine derivatives PFIZER INC (US) 2007-09-18 US disclosed
US-20050037999-A1 Pyrrolopyrimidine derivatives PFIZER INC 2005-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050037999-A1 Pyrrolopyrimidine derivatives CCNA1, CCNT1, TP53 PDGFRB 2465/4885NTRK1 4135/4885NTRK2 4651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.